Michael S. Aberman, SVP Strategy Investor Relation at REGENERON PHARMACEUTICALS INC (REGN), sold 7,500 shares at $417.23 ($3.2M) on 2015-02-24, disclosed to the SEC on 2015-02-25.
Scheduled sale ($3.2M) by SVP Strategy Investor Relation under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $427.94 | 536 | $229K | 7.2% |
| 2 | $427.94 | 3,590 | $1.5M | 48.3% |
| 3 | $416.31 | 600 | $250K | 7.9% |
| 4 | $417.23 | 471 | $197K | 6.2% |
| 5 | $418.33 | 800 | $335K | 10.5% |
| 6 | $419.52 | 1,103 |
| $463K |
| 14.6% |
| 7 | $420.64 | 400 | $168K | 5.3% |
| Total | $423.68 avg | 7,500 | $3.2M | 100% |
| Filing → |
| REGN | SELL | 2015-03-19 | $1.6M | — | Filing → |
| REGN | SELL | 2015-02-18 | $1.5M | — | Filing → |
| REGN | SELL | 2014-08-19 | $1.3M | — | Filing → |